Evidence map›Paper›PMID 26133397›Full record

ArticleScientific reports2015

Resistance of R-Ras knockout mice to skin tumour induction.

Ulrike May, Stuart Prince, Maria Vähätupa, Anni M Laitinen, Katriina Nieminen, Hannele Uusitalo-Järvinen, Tero A H Järvinen

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.4field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 18 citations in OpenAlex.

  1. Proteomics Analysis of R-Ras Deficiency in Oxygen Induced Retinopathy.International journal of molecular sciences · 2023
    Article
  2. Article
  3. Article
  4. Review
  5. Effects of Hexane Root Extract ofBioMed research international · 2019
    Article
  6. Article
  7. Article
  8. Role of carbonic anhydrases in skin wound healing.Experimental & molecular medicine · 2017
    Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Ulrike MaySchool of Medicine, Department of Anatomy and Cell Biology, University of Tampere, Tampere, Finland.
Stuart PrinceSchool of Medicine, Department of Anatomy and Cell Biology, University of Tampere, Tampere, Finland.
Maria VähätupaSchool of Medicine, Department of Anatomy and Cell Biology, University of Tampere, Tampere, Finland.
Anni M LaitinenSchool of Medicine, Department of Anatomy and Cell Biology, University of Tampere, Tampere, Finland.
Katriina NieminenSchool of Medicine, Department of Anatomy and Cell Biology, University of Tampere, Tampere, Finland.
Hannele Uusitalo-Järvinen1] School of Medicine, Department of Anatomy and Cell Biology, University of Tampere, Tampere, Finland [2] Department of Ophthalmology, Tampere University Hospital, Tampere, Finland.
Tero A H Järvinen1] School of Medicine, Department of Anatomy and Cell Biology, University of Tampere, Tampere, Finland [2] Department of Ophthalmology, Tampere University Hospital, Tampere, Finland [3] Department of Orthopedics &Traumatology, Tampere University Hospital, Tampere, Finland.
Tampere University · FITampere University · FITampere University Hospital · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The R-ras gene encodes a small GTPase that is a member of the Ras family. Despite close sequence similarities, R-Ras is functionally distinct from the prototypic Ras proteins; no transformative activity and no activating mutations of R-Ras in human malignancies have been reported for it. R-Ras activity appears inhibitory towards tumour proliferation and invasion, and to promote cellular quiescence. Contrary to this, using mice with a deletion of the R-ras gene, we found that R-Ras facilitates DMBA/TPA-induced skin tumour induction. The tumours appeared in wild-type (WT) mice on average 6 weeks earlier than in R-Ras knockout (R-Ras KO) mice. WT mice developed almost 6 times more tumours than R-Ras KO mice. Despite strong R-Ras protein expression in the dermal blood vessels, no R-Ras could be detected in the epidermis from where the tumours arose. The DMBA/TPA skin tumourigenesis-model is highly dependent upon inflammation, and we found a greatly attenuated skin inflammatory response to DMBA/TPA-treatment in the R-Ras KO mice in the context of leukocyte infiltration and proinflammatory cytokine expression. Thus, these data suggest that despite its characterised role in promoting cellular quiescence, R-Ras is pro-tumourigenic in the DMBA/TPA tumour model and important for the inflammatory response to DMBA/TPA treatment.

Indexed as

9,10-Dimethyl-1,2-benzanthraceneAnimalsApoptosisCell ProliferationDermisGenetic Association StudiesGenetic Predisposition to DiseaseMice, Inbred C57BLMice, KnockoutPapillomaras ProteinsSignal TransductionSkin NeoplasmsTetradecanoylphorbol Acetate9,10-Dimethyl-1,2-benzanthraceneras ProteinsRras protein, mouseTetradecanoylphorbol Acetate

Identifiers

PMID26133397
PMCPMC4488886
OpenAlexW2255205246

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.